Table: Kaken Pharmaceutical - 9-MTH group results

KAKEN PHARMACEUTICAL

06/02/2026 06:32

Feb 6 (Reuters)- 
             Kaken Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2025        Dec 31, 2024     Mar 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             57.62               75.99            86.30    
                 (-24.2 pct)         (+39.0 pct)      (-8.2 pct)  
  Operating        554 mln              25.42             2.10    
                 (-97.8 pct)        (+186.5 pct)      (-90.0 pct) 
  Recurring          1.17               26.08             2.80    
                 (-95.5 pct)        (+180.3 pct)      (-86.8 pct) 
  Net                1.40               19.18             2.30    
                 (-92.7 pct)        (+187.2 pct)      (-83.5 pct) 
  EPS             36.87 yen          506.31 yen        60.74 yen  
  Ann Div                            190.00 yen       190.00 yen  
  -Q2 div         95.00 yen          115.00 yen                   
  -Q4 div                             75.00 yen        95.00 yen  
  
  NOTE - Kaken Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4521.T